Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.
Clemens KüpperJohanna HeinrichKatharina KammVeit BückleinSimon RothenfußerAndreas StraubePublished in: Neurology(R) neuroimmunology & neuroinflammation (2019)